BBLG — Bone Biologics Corp

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1419554 ·
Last close
$0.31
Market Cap
$1.05M
52W High
$2.39
52W Low
$0.27
ADV30
319,821
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -666,340 -617,651 6,432,445 6,088,085 480,775
Jun 2026 0 0 -808,106 -773,702 4,436,668 4,031,780 512,018
Mar 2026 0 — -805,054 -765,988 4,979,305 4,530,040 309,386
Dec 2025 0 — -733,105 -684,643 5,796,135 5,334,322 418,587

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-2,569,759
Investing CF
—
Financing CF
$2,608,760
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.40
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$-90,287,710
Inventory
—
Receivables
$8,977
ST Investments
—
EBIT TTM
$-3,012,605
Pretax Income TTM
$-2,841,984
Interest Exp TTM
—
Analysts
1

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -3,234,942 -3,108,991 5,796,135 418,587 5,377,548 -2,691,150
Dec 2024 0 -4,219,161 -4,112,420 3,861,369 377,712 3,483,657 -4,124,935
Dec 2023 0 -9,428,303 -8,948,731 3,737,763 831,402 2,906,361 -9,555,904
Dec 2022 0 -3,665,173 -1,484,620 8,495,237 2,547,929 5,947,308 -3,566,913
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-2,891,070
OpCashFlow TTM
—
Assets (Latest)
$4,436,668
Forward EPS
$-0.59

Peers — same industry

TickerNameMarket CapLastDaily %
YBGJ Yubo International Biotech Ltd $937.3K $0.01 —
BTCY BIOTRICITY INC. $910.1K $0.05 —
VJET Flyte Aviation, Inc. $890.2K $0.42 —
TNON Tenon Medical, Inc. $833.8K $1.25 —
ESMC ESCALON MEDICAL CORP $1.40M $0.19 —

News headlines (Yahoo Finance, 1h cache)

BBLG Earnings Illustrate Opportunity
2026-10-27 11:06 · Yahoo
Bone Biologics Expands Trial Sites
2026-09-08 12:30 · Yahoo
BBLG Efficiency Improves as Crucial Trials Advance
2026-08-17 12:46 · Yahoo
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances
2026-08-12 14:15 · Yahoo
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
2026-08-12 12:00 · Yahoo
BBLG Secures Financing for Critical Trials
2026-07-08 12:15 · Yahoo
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
2026-07-08 00:00 · Yahoo
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
2025-12-23 13:00 · Yahoo
BBLG In Good Shape as Critical Tests Underway
2026-05-15 12:29 · Yahoo
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
2026-01-08 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.